SMARCB1 and neoplasm: Molecular testing of our patient’s tumor did not demonstrate microsatellite instability, and the tumor mutational burden was low. SMARCB1 had indeterminate results with next-generation sequencing, likely related to low coverage of some or all exons of the gene.